Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trevi Therapeutics, Inc.

6.07
-0.0500-0.82%
Post-market: 6.140.0700+1.15%19:09 EDT
Volume:1.43M
Turnover:8.72M
Market Cap:723.21M
PE:-13.65
High:6.24
Open:6.12
Low:5.98
Close:6.12
Loading ...
Mar 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2023

Correspondence

Form CORRESP - Correspondence
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2023

Major Issues Report

Form 8-K - Current report
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 11, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 14, 2023

Major Issues Report

8-K - Current report
Apr 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Major Issues Report

8-K - Current report
Mar 16, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]